Janus Henderson Group PLC trimmed its position in Omnicell, Inc. (NASDAQ:OMCL) by 34.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 809,086 shares of the company’s stock after selling 422,847 shares during the quarter. Janus Henderson Group PLC owned about 2.13% of Omnicell worth $41,304,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. California Public Employees Retirement System boosted its holdings in Omnicell by 4.2% in the 2nd quarter. California Public Employees Retirement System now owns 81,200 shares of the company’s stock valued at $3,500,000 after purchasing an additional 3,300 shares during the last quarter. Oak Ridge Investments LLC boosted its holdings in Omnicell by 0.6% in the 2nd quarter. Oak Ridge Investments LLC now owns 1,537,940 shares of the company’s stock valued at $66,285,000 after purchasing an additional 8,491 shares during the last quarter. Northern Trust Corp boosted its holdings in Omnicell by 6.0% in the 2nd quarter. Northern Trust Corp now owns 515,757 shares of the company’s stock valued at $22,230,000 after purchasing an additional 29,217 shares during the last quarter. Kornitzer Capital Management Inc. KS boosted its holdings in Omnicell by 20.8% in the 3rd quarter. Kornitzer Capital Management Inc. KS now owns 155,240 shares of the company’s stock valued at $7,925,000 after purchasing an additional 26,700 shares during the last quarter. Finally, GAM Holding AG acquired a new position in Omnicell in the 2nd quarter valued at about $2,866,000. Institutional investors own 99.85% of the company’s stock.

In related news, VP Peter J. Kuipers sold 3,532 shares of the company’s stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of $50.96, for a total transaction of $179,990.72. Following the sale, the vice president now directly owns 40,714 shares of the company’s stock, valued at approximately $2,074,785.44. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Peter J. Kuipers sold 1,926 shares of the company’s stock in a transaction that occurred on Monday, December 18th. The stock was sold at an average price of $51.69, for a total transaction of $99,554.94. Following the sale, the chief financial officer now directly owns 40,544 shares in the company, valued at $2,095,719.36. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 31,090 shares of company stock worth $1,510,221. Company insiders own 3.77% of the company’s stock.

Several equities analysts have recently commented on the stock. Oppenheimer restated a “buy” rating and issued a $55.00 price objective on shares of Omnicell in a report on Tuesday, December 5th. Craig Hallum restated a “buy” rating and issued a $62.00 price objective (up from $52.00) on shares of Omnicell in a report on Monday, October 30th. Cantor Fitzgerald restated a “buy” rating and issued a $60.00 price objective on shares of Omnicell in a report on Tuesday, December 5th. Zacks Investment Research lowered shares of Omnicell from a “hold” rating to a “strong sell” rating in a report on Wednesday, November 1st. Finally, Benchmark upped their price objective on shares of Omnicell from $55.00 to $67.00 and gave the stock a “buy” rating in a report on Tuesday, September 5th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company. Omnicell presently has an average rating of “Buy” and a consensus target price of $55.14.

Omnicell, Inc. (NASDAQ OMCL) opened at $51.45 on Tuesday. The company has a current ratio of 1.53, a quick ratio of 1.08 and a debt-to-equity ratio of 0.38. Omnicell, Inc. has a fifty-two week low of $31.85 and a fifty-two week high of $55.40.

Omnicell (NASDAQ:OMCL) last issued its quarterly earnings data on Thursday, October 26th. The company reported $0.42 EPS for the quarter, hitting the consensus estimate of $0.42. Omnicell had a negative net margin of 0.51% and a negative return on equity of 0.79%. The firm had revenue of $186.78 million for the quarter, compared to analyst estimates of $192.45 million. During the same period in the prior year, the business posted $0.40 EPS. The business’s revenue for the quarter was up 5.7% compared to the same quarter last year. analysts forecast that Omnicell, Inc. will post 0.12 EPS for the current year.

TRADEMARK VIOLATION WARNING: This article was first reported by Daily Political and is the property of of Daily Political. If you are viewing this article on another site, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The correct version of this article can be viewed at https://www.dailypolitical.com/2017/12/19/omnicell-inc-omcl-holdings-trimmed-by-janus-henderson-group-plc.html.

Omnicell Profile

Omnicell, Inc provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence.

Want to see what other hedge funds are holding OMCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omnicell, Inc. (NASDAQ:OMCL).

Institutional Ownership by Quarter for Omnicell (NASDAQ:OMCL)

Receive News & Ratings for Omnicell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell and related companies with MarketBeat.com's FREE daily email newsletter.